Perils of the Pathologic Complete Response

J Clin Oncol. 2016 Nov 20;34(33):3959-3962. doi: 10.1200/JCO.2016.68.1718. Epub 2016 Oct 31.
No abstract available

MeSH terms

  • Clinical Trials as Topic / methods*
  • Disease Progression
  • Disease-Free Survival
  • Endpoint Determination*
  • Humans
  • Neoplasms / mortality
  • Neoplasms / pathology
  • Neoplasms / therapy*
  • Remission Induction
  • Research Design*
  • Risk Factors
  • Time Factors
  • Treatment Outcome